{"gao_id": "GAO-16-594", "published": "2016-07-01T12:00:00Z", "released": "2016-08-01T08:00:00Z", "summary": "", "title": "Medicare Part B: CMS Should Take Additional Steps to Verify Accuracy of Data Used to Set Payment Rates for Drugs", "topics": ["Health services administration", "Average sales price", "Health Care", "Drug pricing", "Reporting requirements", "Health care", "Medicare spending", "Sales", "Physicians", "Medicare payments", "Data integrity", "Statistical data", "Drugs", "Internal controls", "Medicare", "Medicare Part B"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-16-594", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/gao-16-594-highlights.pdf"}, {"title": "Full Report (41 pages)", "url": "https://www.gao.gov/assets/gao-16-594.pdf"}, {"title": "Accessible PDF (46 pages)", "url": "https://www.gao.gov/assets/680/678318.pdf"}]}